Pfizer expands rare disease research with establishment of gene therapy platform
- Details
- Category: Pfizer

Jury verdict favours AstraZeneca in Nexium antitrust litigation
- Details
- Category: AstraZeneca

Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India
- Details
- Category: Bristol-Myers Squibb

Amgen and AstraZeneca announce positive results from third and final pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
- Details
- Category: AstraZeneca

GSK statement on first phase 1 trial results of a candidate Ebola vaccine
- Details
- Category: GlaxoSmithKline

Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration
- Details
- Category: Bristol-Myers Squibb

Novartis Foundation symposium showcases sustainable healthcare interventions
- Details
- Category: Novartis

More Pharma News ...
- Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa® than with warfarin
- Novo Nordisk second best in the world at providing access to medicine
- Bristol-Myers Squibb to construct a new large-scale biologics manufacturing facility in Ireland
- AstraZeneca announces initiation of development programme for BRILINTA® reversal agent
- Roche to invest 450 million Swiss Francs in new diagnostic manufacturing facility in China
- Bayer operationally strong - strategic focus on Life Science businesses
- AstraZeneca launches Healthy Heart Africa programme to address hypertension in Africa